2023
DOI: 10.1016/j.modpat.2023.100116
|View full text |Cite
|
Sign up to set email alerts
|

Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…For example, hyperplasia with and without atypia is a challenging area of gynae pathology with poor reproducibility. Rewcastle et al 17 recently developed an AI tool (ENDOAPP) to assess features within endometrial biopsies with a diagnosis of hyperplasia that correlated with prognosis and were able to assign a low risk versus high risk of progression score with a reasonable level of performance (accuracy of 88-91%), comparable to other classification schemes of hyperplasia such as EIN and WHO 2020.…”
Section: Wsi As a Predictive Biomarkermentioning
confidence: 99%
“…For example, hyperplasia with and without atypia is a challenging area of gynae pathology with poor reproducibility. Rewcastle et al 17 recently developed an AI tool (ENDOAPP) to assess features within endometrial biopsies with a diagnosis of hyperplasia that correlated with prognosis and were able to assign a low risk versus high risk of progression score with a reasonable level of performance (accuracy of 88-91%), comparable to other classification schemes of hyperplasia such as EIN and WHO 2020.…”
Section: Wsi As a Predictive Biomarkermentioning
confidence: 99%